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Abstract: The developing fetus is especially vulnerable to environmental toxicants, including tobacco
constituents. The aim of this study was to assess the impact of environmental tobacco smoke (ETS)
exposure during pregnancy on child neurodevelopment within the first two years of life. The
study population consisted of 461 non-smoking pregnant women (saliva cotinine level <10 ng/mL).
Maternal passive smoking was assessed based on the cotinine level in saliva analyzed by the use of
high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-ESI +
MS/MS) and by questionnaire data. The cotinine cut-off value for passive smoking was established
at 1.5 ng/mL (sensitivity 63%, specificity 71%). Psychomotor development was assessed in children
at the age of one- and two-years using the Bayley Scales of Infant and Toddler Development.
Approximately 30% of the women were exposed to ETS during pregnancy. The multivariate linear
regression model indicated that ETS exposure in the 1st and the 2nd trimesters of pregnancy were
associated with decreasing child language functions at the age of one (β =−3.0, p = 0.03, and β =−4.1,
p = 0.008, respectively), and two years (β = −3.8, p = 0.05, and β = −6.3, p = 0.005, respectively). A
negative association was found for cotinine level ≥1.5 ng/mL in the 2nd trimester of pregnancy
and child cognition at the age of 2 (β = −4.6, p = 0.05), as well as cotinine levels ≥1.5 ng/mL in all
trimesters of pregnancy and child motor abilities at two years of age (β = −3.9, p = 0.06, β = −5.3,
p = 0.02, and β = −4.2, p = 0.05, for the 1st, the 2nd, and the 3rd trimester of pregnancy, respectively;
for the 1st trimester the effect was of borderline statistical significance). This study confirmed that
ETS exposure during pregnancy can have a negative impact on child psychomotor development
within the first two years of life and underscore the importance of public health interventions aiming
at reducing this exposure.
Keywords: environmental tobacco smoke; passive smoking; pregnancy; prenatal period; child
neurodevelopment; cognitive; language and motor functions
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1. Introduction
While the impact of prenatal exposure to tobacco, due to active maternal smoking, on child
neurodevelopment is well established, the association between maternal environmental tobacco smoke
(ETS) exposure during pregnancy and child development has been studied less frequently [1]. This
issue is of great importance, as a large proportion of women are exposed to passive smoking.
During prenatal development the nervous system may be more susceptible to the negative
effects of environmental toxicants, including tobacco constituents [2]. Changes in the brain can
be associated with neurodevelopmental outcomes, such as reduced psychomotor functions and
increased risk of behavioral problems. The possible mechanism involves fetal hypoxia as a result of
reduced utero-placental blood flow and reduced oxygen carrying capacity of blood by the increased
carboxyhemoglobin levels [2–5]. In addition, influence on neurotransmitter function by targeting
nicotine acetylcholine receptors [2,6], upregulation of nicotinic cholinergic receptor binding sites [2,7],
as well as modification of monoaminergic synaptic function [8–10] need to be mentioned. Finally,
tobacco smoke contains many other toxic chemicals, including cadmium and lead, which can affect the
developing nervous system.
The negative impact of ETS exposure during pregnancy on child neurodevelopment including
the risk of developmental delay has been reported in a few studies [11–13]. In addition, some studies
suggest that maternal passive smoking in pregnancy may impact child behavioural development,
particularly aggressive and externalizing behaviours [14–17]. On the other hand, Lee and co-workers
have indicated no impact of prenatal ETS exposure on the psychomotor developmental index score [2],
and Roza and co-workers [18] have pointed out that the statistical association between parental
smoking and behavioural problems was strongly confounded by parental characteristics, mainly
socio-economic status and psychopathology.
In Poland, based on the Global Adult Tobacco Survey that was conducted between the years 2009
and 2010 about 30% of the non-smoking women were exposed to tobacco smoke at home [19]. Our
previous assessments that covered 1771 women from the Polish Mother and Child Cohort (REPRO_PL)
have indicated that about 15% of them can be classified as active, and about 35% as passive smokers
according to their cotinine level in saliva [20]. We have also noted adverse effects of maternal active
smoking during pregnancy on child motor development [21,22].
In view of the above, we hypothesized that environmental tobacco smoke (ETS) exposure during
pregnancy negatively affects child cognitive, language and motor abilities at the age of 1 and 2 years,
and we aimed at verifying this hypothesis using the data from the Polish Mother and Child Cohort
(REPRO_PL). To test the hypothesis the exposure (ETS), outcome (child neurodevelopment at age one
and two years), and confounding variables were defined and appropriate data were collected.
2. Material and Methods
2.1. Study Design and Population
The detailed description of the REPRO_PL cohort and its methodology has been published
previously [23,24]. Briefly, this multicentre prospective study was established in 2007, covering healthy
women (according to the criteria specified in the study protocol) in single, healthy pregnancy of up to
12 weeks of gestation (with no assisted conception and no pregnancy complications).
The women were interviewed by a trained midwife once in each trimester of pregnancy in order
to obtain socio-demographic characteristics, medical and reproductive history, as well as information
on the environmental/lifestyle and occupational exposure.
During each visit and after delivery, biological samples (including saliva, urine, blood, hair, and
cord blood) were collected [23].
When the child achieved one year of age his/her exposure, health status, and neurodevelopment
was assessed by a paediatrician/allergist and a developmental psychologist [24]. A similar procedure
was repeated two years after birth.
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In total, 539 children were examined at least once within two years after their birth (303 children
had both examinations at one and two years of age, 198 were examined only at around the 12th
month of age, and 38 only at the 24th month of age) [25]. Taking into account the fact that the current
study is aimed at the assessment of the impact of maternal ETS exposure during pregnancy on child
neurodevelopment, the smokers were excluded from the analysis and the study sample consisted of
461 (85.5% of the study population) mother-child pairs.
The study was approved by the Ethical Committee of the Nofer Institute of Occupational Medicine
(NIOM), Lodz, Poland (Nos. 7/2007 and 3/2008) and written consent was obtained from all of the
study subjects.
2.2. Exposure Variables
Based on existing knowledge and our previous estimates there is no gold standard for assessment
of ETS exposure [20]. Thus, in our study, prenatal ETS was measured by assessing mother’s
cotinine levels in saliva during pregnancy and, additionally, by collecting (at the same time as the
sample collection) the questionnaire information about their husband/partner smoking and smoking
allowance at home.
At enrolment (the 1st trimester of pregnancy) and each follow-up visit (the 2nd and 3rd
trimesters of pregnancy) the women provided saliva samples into a salivette with citric acid (Sarstedt,
Nümbrecht, Germany). A detailed description of the sample collection and analysis has been
published elsewhere [20,26]. Briefly, the cotinine concentration in saliva was analysed at NIOM
using high-performance liquid chromatography coupled with tandem mass spectrometry/positive
electrospray ionisation (HPLC-ESI + MS/MS) and an isotope dilution method (method accredited by
the Polish Centre of Accreditation: Certificate AB 215), with a limit of detection (LOD) of 0.12 ng/mL
and a limit of quantification (LOQ) of 0.4 ng/mL [20]. Based on the previous assessments, the cut-off
points of 10 ng/mL (sensitivity 96%, specificity 95%) for active smoking and 1.5 ng/mL (sensitivity
63%, specificity 71%) for passive smoking were selected [20]. As it was mentioned above, smokers (the
women with cotinine level ≥10 ng/mL) were excluded from the analysis. The independent variable
was considered as dichotomous (not exposed to ETS: cotinine <1.5 ng/mL vs. exposed to ETS: cotinine
≥1.5 ng/mL).
At the time of saliva collection the women filled in questionnaires that covered two separate
questions about ETS exposure: (1) “Does your husband/partner smoke cigarettes?” and (2) “Is smoking
allowed at your home?” (with the possible answers: yes; no).
The final model evaluates the impact of child prenatal exposure to ETS based on three
variables (cotinine level, husband/partner smoking, and smoking allowance at home) on child
psychomotor development.
2.3. Outcome Variables
The Bayley Scales of Infant and Toddler Development (Bayley 3rd edition) was used to assess
children’s neurodevelopment at one and two years of age. Details regarding child psychomotor
assessment have been published elsewhere [21,22,24]. In the analysis child cognitive, language, and
motor functions were evaluated.
2.4. Counfounding Variables
The following potential confounders were evaluated for the inclusion as covariates in the
regression models: maternal age (at child birth) and education (below high school; high school;
university degree), marital status (married; unmarried), socio-economic status (SES: low; medium;
high), child sex, major pregnancy complications which appeared after inclusion into the study, type of
delivery (vaginal; caesarean), gestational age and birth outcomes, breastfeeding (yes/no and duration
of breastfeeding), number of siblings, day care attendance, alcohol consumption during pregnancy,
and child ETS exposure within the first two years of life.
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SES of the family was measured based on the following question: “What is the financial status of
your family?” Women who declared that they have sufficient money for current expenses and that it is
possible for them to put a substantial sum aside were allocated into the high income category. Those
who indicated sufficient money for current expenses, with possibility to put aside some money were
allocated into the medium category, and those who declared insufficient money for current expenses
into the low income category.
Child ETS exposure after birth was evaluated based on the maternal declaration about her
smoking status within one and two years after delivery (yes; no). Additional analysis was performed
with ETS exposure based on cotinine levels in urine collected from the children at one and two years
of age (taking into account the difficulties in urine collection at young age the urine samples were not
available for all children). The cotinine level was assessed using the same method as described above
(with LOD of 0.05 ng/mL, and LOQ of 0.8 ng/mL). Details regarding covariates assessment have been
described elsewhere [27].
All the confounders with p < 0.10 were included in the final models.
2.5. Statistical Analysis
As it was already specified, our hypothesis was that ETS exposure negatively affected children’s
psychomotor development in the first two years of life. If the null hypothesis of no relationship
between exposure and outcome of interest is rejected, then it can be concluded that such a relationship
exists (alternative hypothesis) with a small Type I error probability. As the first step of analysis,
frequencies for qualitative variables and means ± SD for quantitative variables were calculated. Then
we used the Spearman correlation coefficient to examine the correlation pattern among variables (either
exposure variables or psychomotor developmental scores) and we selected the potential confounding
variables (covariates) to be included in the subsequent regression analyses (based on criteria described
in Section 2.4). Successively, we tested our hypothesis by performing multivariate linear regression,
with cognitive, language, and motor developmental scores at one and at two years of age as dependent
variables in separate analyses, and ETS exposure based on the cotinine level in the mother’s saliva
during different periods of pregnancy as independent variables. The following covariates were
included in the initial models: examiner, mother’s age and education, child sex, and SES. By additional
multivariate regression analyses we simultaneously verified the effect of ETS exposure measured by
the cotinine level in the mother’s saliva during different periods of pregnancy (as above) along with
husband smoking status and smoking allowance at home during pregnancy, and child ETS exposure
after birth based on maternal smoking status. Finally, two additional analyses were performed and
presented in Supplementary Materials: (1) with ETS exposure in the first or second year of life based
on cotinine level in child urine (as potential confounder), and (2) regression analysis stratified by SES.
The variance inflation factor (VIF) was computed for any variable in each model to verify the
presence of multicollinearity among explanatory variables; in the case of VIF values higher than 4 the
corresponding independent variables would be excluded from the model.
Regression coefficients are reported together with their level of statistical significance (p-value).
SPSS (Statistical Package for Social Science, McGraw-Hill Inc., New York, NY, USA) software was used
for the statistical analyses.
3. Results
3.1. Maternal and Child Characteristics
Maternal and child characteristics are summarized in Supplementary Materials (Table S1). A high
percentage of the women were married (78%), had a university degree (68%), and represented medium
or high SES (90%).
The mean composite scores for cognitive, language and motor development were on an average
or a high average level (Table S2). A positive correlation was observed for each subscale of the Bayley
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test results for one year assessment (p < 0.01) and between cognitive and language, as well as motor
and language functions (p < 0.01) for two-year assessment (Table 1). The correlation was weaker for
comparisons performed between one and two years of age.
Table 1. Spearman correlation between the Bayley test results assessments at one and two years of age.
Psychomotor Abilities Assessment at the Age of One Year Assessment at the Age of Two Years
Cognitive Language Motor Cognitive Language Motor
Assessments
at the age of
one year
Cognitive 1
Language 0.28 ** 1
Motor 0.30 ** 0.43 ** 1
Assessments
at the age of
two years
Cognitive 0.09 0.04 0.15 * 1
Language 0.07 0.218 ** 0.14 * 0.49 ** 1
Motor −0.03 0.14 * 0.15 * 0.06 0.37 ** 1
For correlations within the assessment at one year of age N = 427; for correlations between assessments at the age of
one and two years N = 258; for correlations within the assessment at the age of two N = 292. * p < 0.05; ** p < 0.01.
3.2. Characteristics of Pre- and Postnatal ETS Exposure
Characteristics of the exposure variables are presented in Supplementary Materials (Table S2).
Less than 7% of the values for the cotinine level in maternal saliva were below the LOQ. More
than 30% of the women could be classified as exposed to ETS based on their cotinine level in saliva
collected in each trimester of pregnancy. The same percentage of the women indicated that their
husbands/partners smoked cigarettes when they were pregnant (30% in the 1st trimester). This
proportion slightly decreased in the 3rd trimester of pregnancy (27%). Even fewer women reported
that smoking was allowed at their home (21% in the 1st and 17% in the 3rd trimester of pregnancy).
The cotinine levels in each trimester of pregnancy were highly correlated; p < 0.01
(Table 2). Significant, but not strong, correlations were observed between the cotinine levels and
husband/partner smoking status for the 1st and 2nd trimester of pregnancy (p < 0.05). Correlations
between cotinine levels and smoking allowance at home were 0.2 for all trimesters of pregnancy
(p < 0.01). High correlations were identified between observations concerning husband/partner
smoking status as well as smoking allowance at home in the different trimesters of the women’s
pregnancy (r > 0.8 and r > 0.7 respectively; p < 0.01).
About 10% of the mothers indicated tobacco smoking within one year after their child birth.
More than 30% of the children were exposed to ETS because of household members smoking status.
Similar percentages were observed for the period between one and two years of the children’s age (for
maternal smoking within one and two years after delivery: correlation coefficient r > 0.6; for household
smoking status within one and two years after their child birth: r > 0.7; p < 0.01 (Table 2).
3.3. Association between ETS Exposure during Pregnancy Based on Cotinine Level in Maternal Saliva and
Child Neurodevelopment
The multivariate linear regression model indicated a statistically significant negative association
between ETS exposure in the 1st and 2nd trimesters of pregnancy (cotinine level ≥1.5 ng/mL) and
child language development at the age of one and two years (p ≤ 0.03) (Table 3). In addition, passive
smoking in the 2nd trimester of pregnancy was associated with reduced cognitive development among
two-year-old children (p = 0.01). Prenatal ETS exposure had also a negative impact on child motor
abilities in the assessments performed at the age of two years (p ≤ 0.02).
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Table 2. Spearman correlation between indicators of exposure to environmental tobacco smoke (ETS).
ETS Exposure Variables E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12 E13
E1 Cotinine level ng/mL (1st trimester of pregnancy) 1 0.81 ** 0.52 ** 0.19 ** 0.18 ** 0.19 ** 0.23 ** 0.20 ** 0.25 ** −0.01 0.02 0.16 ** 0.19 **
E2 Cotinine level ng/mL (2nd trimester of pregnancy) 1 0.73 ** 0.25 ** 0.24 ** 0.20 ** 0.24 ** 0.20 ** 0.25 ** 0.09 0.10 0.24 ** 0.22 **
E3 Cotinine level ng/mL (3rd trimester of pregnancy) 1 0.14 ** 0.11 * 0.10 0.18 ** 0.14 ** 0.17 ** 0.09 0.05 0.14 ** 0.09
E4 Husband/partner smoking (1st trimester of pregnancy) 1 0.87 ** 0.84 ** 0.38 ** 0.36 ** 0.40 ** 0.17 ** 0.15 * 0.73 ** 0.73 **
E5 Husband/partner smoking (2nd trimester of pregnancy) 1 0.93 ** 0.37 ** 0.41 ** 0.41 ** 0.17 ** 0.13 * 0.76 ** 0.74 **
E6_Husband/partner smoking (3rd trimester of pregnancy 1 0.34 ** 0.38 ** 0.40 ** 0.16 ** 0.17 ** 0.75 ** 0.73 **
E7 Smoking allowed at home (1st trimester of pregnancy) 1 0.75 ** 0.73 ** 0.17 ** 0.18 ** 0.39 ** 0.36 **
E8 Smoking allowed at home (2nd trimester of pregnancy) 1 0.81 ** 0.19 ** 0.19 ** 0.40 ** 0.41 **
E9 Smoking allowed at home (3rd trimester of pregnancy) 1 0.17 ** 0.25 ** 0.39 ** 0.43 **
E10 Maternal smoking within one year after delivery 1 0.63 ** 0.21 ** 0.24 **
E11 Maternal smoking within two year after delivery 1 0.06 0.17 **
E12 Household smoking within one year after delivery 1 0.78 **
E13 Household smoking within two year after delivery 1
* p < 0.05; ** p < 0.01.
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Table 3. ETS exposure during pregnancy based on the cotinine level in saliva and child psychomotor
development at one and two years of age. The multivariate linear regression model.
Cotinine
One-Year-Old Children β (p) N = 427 Two-Year-Old Children β (p) N = 292
Cognitive Language Motor Cognitive Language Motor
1st trimester −0.65 (0.60) −3.01 (0.02) −0.56 (0.69) −3.05 (0.09) −3.81 (0.03) −4.08 (0.02)
2nd trimester −1.06 (0.47) −3.55 (0.02) −0.43 (0.78) −5.33 (0.01) −5.19 (0.009) −5.19 (0.01)
3rd trimester 1.04 (0.42) −0.85 (0.52) 0.85 (0.54) −1.26 (0.51) 0.11 (0.95) −4.38 (0.02)
Cotinine value: 0 = less than 1.5 ng/mL, 1 = equal or greater than 1.5 ng/mL; Adjusted for: socio-economic status
(0 = low, 1 = medium, 2 = high), child sex (0 = girl, 1 = boys), mother’s level of education (0 = below high school level,
1 = high school, 2 = university/college degree), mother’s age at delivery (continuous variable, years), examiner;
For the assessment at the age of one year: 1st trimester N = 355, 2nd trimester = 365, 3rd trimester = 322; For the
assessment at the age of two years: 1st trimester N = 251, 2nd trimester = 199, 3rd trimester = 232; Data are reported
as β-beta coefficients (p-values). Regression coefficients significantly different from 0 are reported in bold.
3.4. Association between ETS Exposure during Pregnancy Based on Cotinine Level in Maternal Saliva,
Husband/Partner Smoking Status, and Smoking Allowance at Home and Child Neurodevelopment
The final model included the same confounding variables mentioned above, with the addition of
child ETS exposure after birth (based on maternal smoking status), and all three indicators of prenatal
ETS exposure (dichotomized: cotinine level, husband smoking and smoking allowance at home)
(Table 4). This analysis confirmed all the associations observed in previous regression analyses. ETS
exposure in the 1st and the 2nd trimesters of pregnancy was associated with reduced child language
functions at the age of one (β = −3.0, p = 0.03 and β = −4.1, p = 0.008, respectively) and two years
(β = −3.8, p = 0.05 and β = −6.3, p = 0.005, respectively). A negative association was found for the
cotinine level ≥1.5 ng/mL in the 2nd trimester of pregnancy and child cognition at the age of two years
(β =−4.6, p = 0.05), as well as cotinine levels≥1.5 ng/mL in all trimesters of pregnancy and child motor
abilities at two years of age (β = −3.9, p = 0.06, β = −5.3, p = 0.02, and β = −4.2, p = 0.05, for the 1st, the
2nd, and the 3rd trimester of pregnancy, respectively; for the 1st trimester the effect was of borderline
statistical significance). In addition, smoking husband/partner when the women was pregnant had a
significant negative impact on child cognitive development at the age of one year (β = −3.3, p = 0.02;
β = −3.5, p = 0.05; β = −3.7; p = 0.02 for the 1st, the 2nd and the 3rd trimester, respectively).
Table 4. ETS exposure during pregnancy based on the selected indicators and child psychomotor
development at the age of one and two years. The multivariate linear regression model.
Variables
One-Year Old Children β (p) N = 427 Two-Year Old Children β (p) N = 292
Cognitive Language Motor Cognitive Language Motor
1st trimester
Cotinine −0.38 (0.77) −3.01 (0.03) 0.41 (0.78) −2.11 (0.29) −3.84 (0.05) −3.85 (0.06)
Husband smoking −3.28 (0.02) 0.92 (0.54) 0.67 (0.68) 1.68 (0.43) 1.41 (0.50) 1.77 (0.42)
Smoking allowed at home 2.43 (0.15) −0.86 (0.62) 0.09 (0.96) −3.96 (0.11) −1.48 (0.54) −1.07 (0.67)
2nd trimester
Cotinine −0.53 (0.72) −4.14 (0.008) 0.06 (0.97) −4.59 (0.05) −6.27 (0.005) −5.27 (0.02)
Husband smoking −3.49 (0.05) −0.20 (0.91) −0.88 (0.64) 1.66 (0.53) 1.83 (0.46) 0.88 (0.74)
Smoking allowed at home 2.64 (0.20) −0.22 (0.92) 0.70 (0.97) −5.07 (0.09) −3.16 (0.26) −0.26 (0.93)
3rd trimester
Cotinine 0.98 (0.46) −1.16 (0.39) 0.69 (0.63) 0.37 (0.85) 0.23 (0.90) −4.16 (0.05)
Husband smoking −3.65 (0.02) −1.34 (0.40) −1.60 (0.35) 0.93 (0.68) 1.71 (0.44) 1.69 (0.49)
Smoking allowed at home 2.02 (0.29) 0.16 (0.93) 0.65 (0.75) −4.96 (0.07) −3.01 (0.26) −1.72 (0.55)
Prenatal exposure indicators: cotinine value (0 = less than 1.5 ng/mL, 1 = equal or greater 1.5 ng/mL); husband
smoking in the specified trimester of pregnancy (0 = No, 1 = Yes); smoking allowed at home in the specified trimester
of pregnancy (0 = No, 1 = Yes). Adjusted for: socio-economic status (0 = low, 1 = medium, 2 = high), child sex
(0 = girl, 1 = boys), mother’s level of education (0 = below high school level, 1 = high school, 2 = university/college
degree), mother’s age at delivery (continuous variable, years), maternal smoking within one year after delivery
(0 = No, 1 = Yes), examiner; For the assessment at the age of 1-year: 1st trimester N = 342, 2nd trimester = 253, 3rd
trimester = 310; For the assessment at the age of 2-year: 1st trimester N = 221, 2nd trimester = 179, 3rd trimester = 211;
Data are reported as β-beta coefficients (p-values). Regression coefficients significantly different from 0 are reported
in bold.
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Additional regression analysis was performed on a subset of children, using cotinine in their urine
as potential confounders in the model (Table S3). Results of this analysis are in substantial accordance
with those presented in Table 4, thus supporting the reliability of the questionnaire data in measuring
the postnatal exposure to smoking.
3.5. Association between ETS Exposure during Pregnancy Based on the Cotinine Level in Maternal Saliva and
Child Neurodevelopment—Analysis Stratified by Maternal SES
The analysis stratified by maternal SES (low/medium and high) is presented in Supplementary
materials (Tables S4 and S5). Associations between exposure and child neurodevelopment were
roughly comparable in the two strata, except for the language domain, where high SES exerts a
protective role on the development likely overshadowing the effect of other risk factors. However,
significant effects of exposure were observed only in the low/medium SES group, likely due to the
larger sample size.
4. Discussion
The present study showed that 30% of the non-smoking women were exposed to ETS during the
pregnancy period. Children of the mothers who were passive smokers while pregnant had decreased
neurodevelopmental abilities compared with children of the non-exposed mothers. This association
was observed for the whole spectrum of child neurodevelopment, including cognitive, language, and
motor abilities.
In the studies assessing ETS exposure on early development of children, a reliable assessment of
passive smoking and psychomotor abilities is the most challenging issue. In the current study we used
three indicators of ETS exposure, i.e., cotinine levels in saliva, husband/partner smoking status, and
allowance of smoking at home. It seems that the cotinine level can give a better estimate of exposure
than the questionnaire data [28–31]. ETS assessment based on a husband/partner’s smoking status and
exposure at home or in public places might lead to a misclassification, especially during the pregnancy
period. The existing studies in this field have selected a variety of indicators of ETS exposure including:
the number of cigarettes smoked daily in the presence of a mother over the period of pregnancy [13], at
least one person that smoked in a woman’s environment for at least 30 minutes [14], paternal smoking
outdoors and indoors [18], ever smelt tobacco smoke at home, in the workplace and/or outdoors [2],
or the cotinine level in umbilical cord blood [12]. Based on our previous assessment (on the REPRO_PL
cohort) nearly 30% of the non-smokers who indicated that smoking was not allowed at their home
could be classified as exposed to passive smoking based on the cut-off value [20]. The differences in
the methods selected for exposure assessment can lead to differences between the studies with respect
to the percentages of women exposed to ETS during pregnancy and the strength of the association
between the exposure of interest and child neurodevelopment. The proportion of the women exposed
to ETS in our study is in agreement with the data from a representative survey conducted in Poland at
a similar time point (30% of the non-smoking women exposed to ETS at home). A similar percentage
(37%) of women exposed to ETS has been reported by Liu et al. [14]. A slightly lower percentage of
newborns exposed to ETS in the prenatal period based on the cord blood cotinine has been observed
in the Taiwan Birth Panel Study (25%) [12]. In the study by Roza et al. among never smokers, paternal
smoking has been indicated by 32% of the study women and of them those who gave up smoking
before pregnancy constituted 44% [18]. A considerably higher percentage of passive smokers in the
period of pregnancy has been observed in Korea (64%) [2].
Several reviews suggest associations between maternal smoking during pregnancy (including
active and passive smoking) and reduced child psychomotor abilities, as well as behavioural problems.
They also underline the importance of controlling for a variety of confounding factors [3,32–36].
In the study conducted in South Korea (Seoul, Cheonan, and Ulsan) and in Poland (Krakow)
child psychomotor development has been assessed using the Bayley Scales of Infant Development
(BSID-II)—the earliest version of the test, which was used in the current study [2,13]. Similarly to
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our assessments, they have found a negative impact of prenatal ETS exposure on the Child Mental
Development Index score (as a combination of early cognitive and language development) [37]. On the
contrary, Lee and co-workers have not observed any impact of the exposure of interest on the child
Psychomotor Developmental Index score [2].
A Taiwanese cohort study has reported a negative association between cotinine levels and
two-year-old children’s neurodevelopment assessed by the developmental quotients of the whole
test and cognitive, language, fine motor, and social subtests of the Comprehensive Developmental
Inventory for Infants and Toddlers [12]. Those authors have concluded that CYP1A1 Ile462Val and
GSTT1 metabolic genes can modify the effect of cord blood cotinine on early child neurodevelopment,
especially in terms of language and fine motor development. Rauh and co-workers have concluded
that prenatal exposure to ETS has a negative impact on two-year-olds’ cognitive development, an effect
that is exacerbated under conditions of material hardship [11]. Differences in those studies’ findings
can be related to the differences in exposure and outcome assessments (different sensitivities of the
selected measures), child age at the assessment, as well as control for confounding factors.
The strengths of the current study include a large sample size of validated non-smoking mothers
(and their children followed up to two years of age) from the prospective cohort (REPRO_PL).
In addition, repeated cotinine measurements throughout the whole pregnancy period and the
questionnaire data obtained at the time of sample collection allows a more accurate exposure
assessment. The series of detailed questionnaires also allow a reliable assessment of the covariates.
Additionally, by restricting our population to healthy women, we were able to eliminate additional
confounding variables. Finally, the study considered multiple aspects of child development.
However, the study has also some limitations. Firstly, even though the analysis included a
variety of factors associated with passive smoking and child psychomotor development, it did not
include the quality of the home environment, mother-child relationship, performing parental roles, or
maternal IQ. SES can be considered a reliable proxy for most of these variables (IQ, job, and familial
income). Marital status was associated to SES, with unmarried mothers having a SES significantly
lower than married mothers. In addition, children of married and unmarried mothers did not differ as
for cognitive, language, and motor Bayley scores at one-year and two-year assessments. As a matter
of fact, the significant impact of numerous confounding factors in the analysis focusing on ETS and
child neurodevelopment has been illuminated by Roza et al. [18]. Nevertheless, we did control (or
considered for confounding effect) for maternal education, SES, number of siblings, and day care
attendance as surrogate markers. Another limitation, which was also illuminated by Hsieh et al.,
is the possibility of a considerable overlap between prenatal and postnatal ETS exposure [12]. The
Spearman correlation analysis was used to test the correlation between maternal (during the pregnancy
period) and children’s (after birth) ETS exposure. Since the correlations between different indicators of
maternal ETS exposure during pregnancy and maternal smoking after child birth were low (r < 0.2),
the postnatal child ETS exposure was included as a confounding variable in the model. The negative
impact of prenatal ETS exposure persisted even after adjusting for postnatal ETS. We also need to
consider the limitation related with the use of standardized development assessment methods in
early childhood. On one hand, they give the unique possibility for making comparisons between
children based on “objective” developmental indices, which is crucial for epidemiological studies.
On the other hand they are affected by measurement errors related to child’s general status at the
time of examination and examiners’ approach [38]. Especially in the case of infants up to one year,
reliable examination of neurodevelopment is challenging. Moreover, we also need to consider that the
correlations obtained at the age of one year are not always confirmed at the age of two years. This
might be the result of dynamic and, usually, at least to some extent, unbalanced development at this
period of life which depends on environmental stimulation and attachment style, both depending on
the characteristics of the child’s parents [39–42]. These factors that potentially affect child development
were not controlled in our study.
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5. Conclusions
The current study demonstrates a negative impact of maternal ETS exposure during pregnancy on
child psychomotor development, including cognitive, language, and motor abilities within the first two
years of life. Our findings indicate that increased public awareness, health education, and intervention
programs, simultaneously with adequate legislation, still require considerable improvement. Future
studies are needed to determine whether the observed decrements in child psychomotor abilities have
a long-term effect.
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/14/7/796/S1,
Table S1: Child and parental characteristics; Table S2: Characteristics of exposure and outcome variables; Table S3:
ETS exposure during pregnancy based on selected indicators and psychomotor development at one and two
years. Multiple linear regression model; Table S4: Socio-economic status: Low/Medium. ETS exposure during
pregnancy based on the cotinine level in saliva and child psychomotor development at one and two years of age.
Multiple linear regression model; Table S5: Socio-economic status: High. ETS exposure during pregnancy based
on the cotinine level in saliva and child psychomotor development at one and two years of age. Multiple linear
regression model.
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